Concentration-response relationship of levodopa in patients at different stages of Parkinson's disease (Q64870012)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9728899%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Concentration-response relationship of levodopa in patients at different stages of Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9728899%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

Harder S

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9728899%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Baas H

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9728899%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9728899%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

3 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9728899%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9728899%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9728899%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

183-191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9728899%20AND%20SRC:MED&resulttype=core&format=json

Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Contemporary approaches to the pharmacotherapeutic management of Parkinson's disease: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Clinical pharmacokinetics of anti-parkinsonian drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Clinical significance of the relationship between O-methyldopa levels and levodopa intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

The natural history of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Concentration-effect relationship of levodopa in patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Pharmacodynamic modeling of concentration-effect relationships after controlled-release carbidopa/levodopa (Sinemet CR4) in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Pharmacokinetics and effects of levodopa in advanced Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Pharmacodynamic modeling of oral levodopa: clinical application in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Aromatic Amino Acids and Modification of Parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Parkinsonism: onset, progression, and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Concentration-effect relationship of levodopa in patients with Parkinson's disease after oral administration of an immediate release and a controlled release formulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating parkinsonian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Population pharmacokinetics and pharmacodynamics of oral levodopa in parkinsonian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Relationship between levodopa concentration, dyskinesias, and motor effect in parkinsonian patients: a 3-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Levodopa induces apoptosis in cultured neuronal cells--a possible accelerator of nigrostriatal degeneration in Parkinson's disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Is levodopa toxic to human substantia nigra?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

Effects of 3-OM-dopa on monoamine metabolism in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

3-O-methyldopa and the response to levodopa in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990152-7

10.1016/S0009-9236(98)90152-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9728899%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference